Similarly, the overall survival of stage II CRC patients with high ACP2 expression had a tendency towards poor prognosis (P = 0.093, Figure 1H), but again this was not the case with stage III CRC patients (P = 0.281, Figure 1I). The gene discussed is ACP2; the disease is colorectal carcinoma.